Safety and Pharmacokinetics of Kovacaine Nasal Spray (24 Hour Blood Collection)
Status:
Completed
Trial end date:
2013-03-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to determine the pharmacokinetics/pharmacodynamics and safety of
a nasal spray containing the anesthetic drug tetracaine in combination with oxymetazoline
with blood draws over 24 hours.
Phase:
Phase 2
Details
Lead Sponsor:
St. Renatus, LLC
Collaborators:
Analytical Bio-Chemistry Laboratories, Inc. Rho, Inc. Triligent International